Pipeline top-up drives Merck/Schering-Plough merger
This article was originally published in Scrip
Executive Summary
Although Merck & Co has managed to avoid the large-scale acquisition route to replenish its pipeline in the past, it now looks like it could have reached the point where it has run out of viable strategic alternatives, and this was likely one of the factors that drove it into the arms of Schering-Plough.